Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum

CLEVELAND, July 08, 2024 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO) today announced that Abeona's Chief Executive Officer, Vish Seshadri, Ph.D., M.B.A., and Chief Commercial Officer, Madhav

GlobeNewswireJul 8 19:30

H.C. Wainwright Initiates Abeona Therapeutics(ABEO.US) With Buy Rating, Announces Target Price $15

H.C. Wainwright analyst Ram Selvaraju initiates coverage on $Abeona Therapeutics(ABEO.US)$ with a buy rating, and sets the target price at $15.According to TipRanks data, the analyst has a success rat

Futu NewsJul 3 18:31 · Ratings

Buy Rating Affirmed for Abeona Therapeutics on Promising Pz-cel Therapy for RDEB

TipRanksJul 3 18:16

Express News | Abeona Therapeutics Inc : H.c. Wainwright Initiates Coverage With Buy Rating; Target Price $15

BreakingsJul 3 18:05

Abeona Therapeutics Independent Director Mark Alvino Sells 41% Of Holding

We'd be surprised if Abeona Therapeutics Inc. (NASDAQ:ABEO) shareholders haven't noticed that the Independent Director, Mark Alvino, recently sold US$117k worth of stock at US$4.51 per share. That

Simply Wall StJun 25 02:41

Insider Sale: Director Christine Silverstein Sells Shares of Abeona Therapeutics Inc (ABEO)

Yahoo FinanceJun 21 15:08